drugset / Trial / NCT02854904

Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion

NCT02854904

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Alpha-agonist in anesthesia display immunomodulatory effect in addition to antiadrenergic control. This effect of the immune system can be a key to a better perioperative safety and quality. The association of dexmedetomidine at general anesthesia adds up organic protection and inflammatory control to a surgery trauma owing to antinociception and immunomodulatory effect. The aim this study is evaluate if the association of dexmedetomidine at general anesthesia standing effective immunomodulatory control to trauma and improve changes at outcomes in patients undergoing to spinal fusion.

Timeline

Start
2016-08
Primary completion
2016-11
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous